A bill to address the health of cancer survivors and unmet needs that survivors face through the entire continuum of care from diagnosis through active treatment and posttreatment, in order to improve survivorship, treatment, transition to recovery and beyond, quality of life and palliative care, and long-term health outcomes, including by developing a minimum standard of care for cancer survivorship, irrespective of the type of cancer, a survivor's background, or forthcoming survivorship needs, and for other purposes.

119th Congress Introduced by Angela Alsobrooks and 1 co-sponsor

Establish a nationwide minimum standard of cancer survivorship care covering diagnosis through long-term follow-up to improve quality of life and outcomes.

Introduced in Senate

Summary of Bill: S 5052 (119th Congress)

Purpose and Intent

The bill aims to address the health and unmet needs of cancer survivors throughout the entire continuum of care—from diagnosis, through active treatment, to post-treatment recovery and long-term survivorship.

It seeks to improve survivorship, treatment transitions, quality of life, palliative care, and long-term health outcomes.

A central objective is to develop a minimum standard of care for cancer survivorship that applies irrespective of cancer type, survivor background, or anticipated survivorship needs.

Key Provisions and Changes

Establishment of a minimum standard of care for cancer survivorship across all cancer types.

Focus on comprehensive survivorship care that covers:

Initial diagnosis period
Active treatment phase
Transition to recovery and ongoing survivorship
Long-term monitoring and management of late or chronic effects
Palliative care and quality of life improvements

Emphasis on addressing unmet needs survivors face, including medical, psychosocial, and supportive care.

Potential framework for implementing standardized survivorship guidelines, care pathways, or required practices for healthcare providers and systems.

Affected Parties and Scope

Cancer survivors and patients at risk of cancer-related late effects.

Healthcare providers and systems delivering cancer care (oncologists, primary care physicians, survivorship coordinators, palliative care teams).

Health plans and payers that would be involved in delivering or reimbursing survivorship-related services, depending on further provisions.

Federal or state health-related agencies responsible for developing guidelines and overseeing implementation (as specified by the bill’s text).

Procedural and Timeline Aspects

The bill was introduced in the Senate and referred to the Committee on Finance.

Introduced date: July 21, 2026.

Parliamentary steps to follow (subject to bill advancement): potential committee hearings, amendments, Senate floor consideration, and alignment with related health policy or appropriations actions.

Notable sponsors: Co-sponsors include Angela Alsobrooks and Amy Klobuchar, indicating bipartisan or cross-aisle support in some instances.

Potential Impact (Policy and Practice)

Creates a baseline standard of survivorship care, which could influence clinical guidelines, care coordination, and follow-up protocols.

May improve consistency of survivorship services across providers and settings, potentially reducing variation in care quality.

Could inform funding needs and reimbursement policies to support survivorship programs, surveillance for late effects, and integration of palliative care.

Aims to improve long-term outcomes and quality of life for cancer survivors, including physical, emotional, and social dimensions of health.

Notes for Readers

Specific details such as the exact statutory language, defined terms (e.g., “minimum standard of care for cancer survivorship”), funding mechanisms, and implementation timelines will be clarified in the bill’s text and any reported committee amendments.

As of the latest action, the bill is at the Committee on Finance stage; no enacted provisions are in effect until the legislative process is completed.